Buckel E, Silva G, Brahm J, Zacarías J, Ceresa S, Carvajal C, Lizana C, Uribe M, Blanco A, Valdés S, Cordero J, Santelices E, Iñguez A, Coloma R, Morales J, Smok G, Herzog C
Unidad de Trasplantes de Organos, Clínica Las Condes, Santiago de Chile.
Rev Med Chil. 1996 Jan;124(1):27-36.
Orthotopic liver transplantation (THO) is the treatment of choice for a variety of liver diseases. The national experience before 1993 has been scarce. In November 1993 we started our experience in THO at Clínica Las Condes, as part of a multiorgan transplant program (liver, kidney, pancreas). Until January 1995 we have performed 14 THO in 13 recipients (one retransplantation), of which 5 were in pediatric cases. The recipients range of age fluctuated between 1 and 61 years. In two pediatric cases a liver allograft reduction was performed. Six recipients (46%) required treatment for acute cellular rejection. One recipient had an hepatic artery thrombosis and had to be retransplanted. There was no operative mortality up to 30 days in cases of primary liver transplants. The retransplanted adult recipient, and another pediatric recipient that died from a late recurrence of a hepatoblastoma, accounted for the mortality of this experience. After an average follow up of 10 months, the actual patient survival in 85%. Of the 11 surviving recipients, 9 are in excellent conditions with a very good quality of life. This experience shows that an active liver transplant program in our country can be successful in obtaining results comparable to those published by very experienced foreign transplant centers.
原位肝移植(THO)是多种肝脏疾病的首选治疗方法。1993年以前国内这方面的经验很少。1993年11月,我们在拉斯孔德斯诊所开始了原位肝移植经验,作为多器官移植项目(肝脏、肾脏、胰腺)的一部分。到1995年1月,我们已对13名受者进行了14例原位肝移植(1例再次移植),其中5例为儿科病例。受者年龄范围在1至61岁之间。在2例儿科病例中进行了肝脏同种异体移植减容。6名受者(46%)需要治疗急性细胞排斥反应。1名受者发生肝动脉血栓形成,不得不再次移植。原发性肝移植病例术后30天内无手术死亡。再次移植的成年受者以及另1名因肝母细胞瘤晚期复发死亡的儿科受者构成了该经验中的死亡病例。平均随访10个月后,实际患者生存率为85%。在11名存活的受者中,9名情况良好,生活质量很高。该经验表明,我国积极开展的肝移植项目能够成功取得与经验丰富的国外移植中心公布的结果相当的成果。